Lipella Pharmaceuticals Inc. Common Stock (LIPO NASDAQ) stock market data APIs
$0.0259
0(0%)
as of May 7, 2026
Try our APIs with
free plan!
Lipella Pharmaceuticals Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. On March 30, 2026, Lipella Pharmaceuticals Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.
Prev. Close
0.0259
Open
0.0259
High
0.0259
Low
0.0259
52 wk Range
0.02-3.17
Market Cap
143 K
Shares Outstanding
4 621 K
Revenue
390 K
EPS
0
Beta
0.841
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lipella Pharmaceuticals Inc. Common Stock data using free add-ons & libraries
Get Lipella Pharmaceuticals Inc. Common Stock Fundamental Data
Lipella Pharmaceuticals Inc. Common Stock Fundamental data includes:
- Net Revenue: 390 K
- EBITDA: -5 407 074
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Lipella Pharmaceuticals Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-02-25
- EPS/Forecast: 0
Get Lipella Pharmaceuticals Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lipella Pharmaceuticals Inc. Common Stock News
New
Lipella Pharmaceuticals Files For Chapter 11 Bankruptcy Protection
(RTTNews) - Lipella Pharmaceuticals Inc. announced that it has filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the Western ...
Nasdaq to delist certain securities suspended from trading
[The NASDAQ Stock Exchange headquarters in New York, USA] JHVEPhoto/iStock Editorial via Getty Images Nasdaq (NASDAQ:NDAQ [https://seekingalpha.com/symbol/NDAQ]) on Wednesday announced [https://seeki...
Delisting of Securities from The Nasdaq Stock Market
Nasdaq, Inc. NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the warrants of Digital Brands Group, Inc. Digital Brands Group, Inc.’s warrant...
Top Buys by Directors: Huffines's $112.1K Bet on GBX
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a compan...
Get Lipella Pharmaceuticals Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
